Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Lumos Pharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 41 | 40 | −1 |
| Shares | 3.32M | 3.20M | −112.4K (−3.4%) |
| Value | $38.8M | $32.1M | −$6.73M (−17.3%) |
New holders (5)
Institutions that held Lumos Pharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Price T Rowe Associates Inc | 159,595 | $1.59M | 0.00% |
| Paragon Associates & Paragon Associates II Joint Venture | 50,000 | $500.0K | 0.67% |
| State Street Corp | 11,237 | $112.0K | 0.00% |
| Marquette Asset Management, LLC | 8,919 | $89.0K | 0.02% |
| Captrust Financial Advisors | 400 | $4.00K | 0.00% |
Sold out (6)
Institutions that held Lumos Pharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Two Sigma Investments, LP | 10,519 | $123.0K |
| Citigroup Inc | 1,000 | $12.0K |
| International Assets Investment Management, LLC | 222 | $8.00K |
| Steward Partners Investment Advisory, LLC | 344 | $4.03K |
| Meeder Asset Management Inc | 119 | $1.00K |
| Clearstead Advisors, LLC | 35 | $0 |